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Abstract: Chrysopogon zizanioides (L.) Roberty, Poaceae, is a plant widely used in 
northeast Brazil in folk medicine for the treatment of various pathological conditions, 
including infl ammatory pain. The present study evaluated the antinociceptive and anti-
infl ammatory effects of C. zizanioides essential oil (EO) in rodents. EO was further 
characterized by GC/MS. The major components of EO were identifi ed as khusimol 
(19.57%), E-isovalencenol (13.24%), α-vetivone (5.25%), β-vetivone (4.87%) and 
hydroxy-valencene (4.64%). Following intraperitoneal injection (i.p.), EO at 50 and 
100 mg/kg signifi cantly reduced the number of writhes (51.9 and 64.9%, respectively) 
and the number of paw licks during phase 2 (56.7 and 86.2%, respectively) of a 
formalin model when compared to control group animals. However, EO-treated mice 
were ineffective at all doses in hot-plate and rota-rod tests. The EO inhibited the 
carrageenan-induced leukocyte migration to the peritoneal cavity in a dose-dependent 
manner (34.7, 35.4, and 62.5% at doses of 25, 50 and 100 mg/kg, respectively). In the 
paw edema test, the EO (100 mg/kg) inhibited all three phases of the edema equally 
well, suggesting that the EO has a non-selective inhibitory effect on the release or 
actions of these mediators. Our results suggest possible antinociceptive and anti-









 Medicinal plants are known as an important 
source of new chemical substances with potential 
therapeutic effects (Almeida et al., 2001). Recently, 
essential oils extracted from various herbs and spices 
have been a subject of intensive research, partially due 
to the continuous discoveries of their multifunctional 
properties other than their classical roles as food additives 
and/or fragrances. For example, antibacterial, antifungal, 
anticonvulsant, antinociceptive and anti-infl ammatory 
activities of many essential oils have been investigated 
(Elisabetsky et al., 1995; Hammer et al., 1999; Almeida et 
al., 2001; Quintans-Junior et al., 2008). 
 Chrysopogon zizanioides Nash, Poaceae, 
popularly known as vetiver and “grama-das-índias”, is 
one of the most important raw materials in perfumery 
(Martinez et al., 2004). The genus Vetiver has recently 
been reclassifi ed (Adams et al., 1998), and is now 
combined with Chrysopogon (Veldkamp, 1999), based 
on their overlapping genetic and morphological data. This 
led to the recognition of C. zizanioides (L.) Roberty as the 
correct classifi cation for Vetiveria zizanioides (L.) Nash 
(Massardo et al., 2006). Except for termiticidal (Maistrello 
et al., 2001) and antimicrobial activities (Hammer et al., 
1999), the oil has not been studied intensively concerning 
other biological functionalities, probably because of its 
complex constituents. Vetiver oil is composed of more 
than 170 compounds that are mainly sesquiterpenes and 
their derivatives (Nigam et al., 1968; Weyerstahl et al., 
2000b). 
 Despite the traditional use as analgesic 
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and sedative in Brazil, no reports concerning the 
antinociceptive effects of vetiver are available. Besides, 
the properties of vetiver regarding free radicals and 
oxidative damage have never been studied. Considering 
the role of reactive oxygen species (ROS) in physiological 
and pathophysiological processes, and also considering 
that secondary metabolites have been observed to exert 
multiple roles in response to ROS-mediated insults when 
administered therapeutically or used in the diet, it is 
important to investigate redox-associated properties of 
compounds derived from natural sources. In this regard, 
we studied the antinociceptive and anti-inflamatory 
effects of essential oil of C. zizanioides in rodents, as 
well as some of its redox properties in vitro.
Material and Methods
Plant material and essential oil (EO) extraction
 Roots were collected from the cultivation 
of Chrysopogon zizanioides (L.) Roberty, Poaceae, 
genotypes established at the Research Farm "Campus 
Rural da UFS" of the Federal University of Sergipe, 
Brazil, and a voucher sample has been deposited in 
the Herbarium of the Department of Biology, Federal 
University of Sergipe (ASE 13437). The roots of 
C. zizanioides were oven dried with air renewal and 
circulation (model MA-037/18) at 40 ºC until complete 
dehydration has been achieved. The essential oil (EO) 
was obtained by hydrodistillation in a Clevenger-type 
apparatus using 250 g of dried roots. The essential 
oil (EO) obtained was dried over anhydrous sodium 
sulfate, producing yields of 4.15% (v/w).
Analysis of the essential oil by GC/MS
 A Shimadzu system (Kyoto, Japan), consisting 
of a QP-5050A mass spectrometer equipped with a GC-
17A gas chromatograph with a Shimadzu AOC 20i auto-
injector and a split (ratio 1:83) injector was used for 
the identification and quantification of the EO studied. 
A fused silica column DB-5MS (30 m x 0.25 mm i.d, 
composed of 5% phenylmethylpolysiloxane), supplied by 
J&W Scientific (Folsom, CA, USA), was employed, with 
helium (99.999% purity) as carrier gas at a flow-rate of 
1.2 mL/min. The column temperature was programmed as 
follows: 50 °C for 1.5 min, then directly to 200 °C at 4 
°C/min, them 10 oC/min to 300 oC, ending with a 10 min 
isothermal at 300 oC. The injector port was maintained at 
250 °C, ion-source temperature 280 °C and 0.5 L sample 
volumes were injected. The mass spectra were taken at 
70 eV with scanning speed of 0.85 scan/s from 40 to 550 
Da. The data were acquired and processed with a PC with 
Shimadzu Class-5000 software. The identification of the 
constituents was assigned on basis of comparison of their 
relative retention indices (Van Den Dool & Kratz, 1963) to 
a n-alkane homologous series (nC9-nC18) obtained by co-
injecting the oil sample with a linear hydrocarbon mixture, 
as well as, by computerized matching of the acquired 
mass spectra witch those stored in NIST21 and NIST107 
mass spectral libraries of the GC/MS data system and 
other published mass spectra (Adams, 2007; Adams et al., 
2008).
Animals
 Male Swiss mice weighing 25-35 g, maintained 
under standard environmental conditions, were used 
distributed in groups of ten (writhing, formalin, hot-plate 
and rota-rod tests) and six male Wistar rats weighing 150-
180 g each (neutrophil migration activity and carrageenan-
induced hind paw edema). The animals were randomly 
housed in appropriate cages at 22±1 oC on a 12 h light/
dark cycle (lights on 6 am to 6 pm) with free access to food 
and water. Experimental protocols and procedures were 
approved by the Federal University of Sergipe Animal 
Care and Use Committee (CEPA/UFS 23/08).
Acetic acid-induced writhing
 In this model (Koster et al., 1959), groups of 
mice were administered 0.85% acetic acid (10 mL/kg 
body wt., i.p.), and the number of abdominal contractions 
was registered over 20 min, starting 5 min after acetic 
acid injection. Animals (n=10, per group) were treated 
intraperitoneally (i.p.) with EO (25, 50, and 100 mg/kg), 
30 min before acetic acid administration. Distilled water 
with one drop of tween 80 0.2% (vehicle) was used i.p. in 
control animals. The effect of pretreatment with naloxone 
(NAL, 1.5 mg/kg, i.p.) on the antinociception produced by 
EO (50 and 100 mg/kg) and morphine (MOR, 3.0 mg/kg, 
i.p.) was determined.
Formalin test 
 The formalin test was carried out as described by 
Hunskaar et al. (1985). The animals were separated into 
five groups (n=10, per group) and treated i.p. with vehicle 
(control), EO (25, 50, and 100 mg/kg) and aspirin (200 
mg/kg). After 30 min, 20 µL of 2.5% formalin solution 
(0.92% formaldehyde in 0.9% saline) was injected into 
the subplantar area of the right hindpaw. The duration of 
paw licking was measured at 0-5 min (first phase) and 
15-30 min (second phase) after formalin administration 
(Hunskaar & Hole, 1987).
Hot-plate test
 The hot-plate test measured response latencies 
according to the method described by Eddy & Leimback 
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(1953). Animals were placed on an Insight® hot-plate 
(Model EFF-361) maintained at 55±1 °C and the time 
between placement of the animal on the hot-plate and the 
occurrence of either the licking of the hind paws, shaking 
or jump off from the surface was recorded as response 
latency. Mice with baseline latencies of more than 10 s 
were eliminated from the study 24 h later. The cut-off time 
for the hot plate latencies was set at 30 s. Animals (n=10, 
per group) were treated with EO (25, 50, and 100 mg/
kg, i.p.) 30 min before the experiments. Animals control 
received the same treatment to abdominal constriction 
test.
Rota-rod test
 Mice able to remain on the Rota-rod apparatus 
(AVS®, Brazil) longer than 180 s (9 rpm) were selected 24 
h before the test according to Gonçalves et al. (2008). Then 
the selected animals were divided into five groups (n=8) 
and treated i.p. with vehicle (control), EO (25, 50, and 100 
mg/kg), and diazepam (1.5 mg/kg). Thirty minutes later, 
each animal was tested on the Rota-rod and the time (s) 
they remained on the bar for up to 180 s was recorded.
Carrageenin-induced hind paw edema in rats
 The acute hind paw edema was produced 
by injecting 0.1 mL of carrageenan (prepared as 1% 
suspension in sterile normal saline) locally into the plantar 
aponeurosis of the right hind paw of rats (Winter et al., 
1962). EO (50, 100, and 200 mg/kg, i.p.) was administered 
to three different groups while the other two groups served 
as negative and positive controls and received vehicle and 
standard drug, Aspirin (300 mg/kg, p.o.), respectively. EO 
and aspirin were administered 1 h prior to the injection of 
carrageenan. The rat pedal volume up to the ankle joint 
was measured using plethysmometer (Model LE 7500 
Panlab, Barcelona, Spain) at 0 (just before) and 3 h after 
the injection of carrageenan. 
Leukocyte migration to the peritoneal cavity
 The leukocyte migration was induced by 
injection of carrageenan (500 µg/cavity, i.p., 500 µL) into 
the peritoneal cavity of rats 30 min after administration of 
EO (25, 50, and 100 mg/kg, i.p.) or dexamethasone (2 mg/
kg, s.c., n=6) by modification of the technique previously 
described by Bastos et al. (2007). The animals were 
euthanized by cervical dislocation 4 h after carrageenan 
injection. Shortly after, phosphate buffered saline (PBS) 
containing EDTA (1 mM, i.p., 10 mL) was injected. 
Immediately a brief massage was done for further fluid 
collection, which was centrifuged (2000 rpm, 5 min) at 
room temperature. The supernatant was disposed of 1 
mL of PBS was introduced to the precipitate. An aliquot 
of 10 μL from this suspension was dissolved in 200 μL 
of Turk solution and the total cells were counted in a 
Neubauer chamber, under optic microscopy. The results 
were expressed as the number of neutrophils/mL. The 
percentage of the leukocyte inhibition = (1–T/C)x100, 
where T represents the treated groups leukocyte counts 
and C represents the control group leukocyte counts.
TBARS Assay
 TBARS (thiobarbituric acid reactive species) 
assay was employed to measure the antioxidant capacity 
of EO using egg yolk homogenate as lipid rich substrate. 
Briefly, egg yolk was homogenized (1% w/v) in 20 mM 
phosphate buffer (pH 7.4), 1 mL of homogenate was 
sonicated (10 s in potency 4) and then homogenized with 
0.1 mL of EO at different concentrations or controls in 
different concentrations prepared immediately before use. 
Lipid peroxidation was induced by addition of 0.1 mL of 
(2,2’-azobis[2-methylpropionamidine]dihydrochloride) 
(AAPH, a free radical source) solution (0.12 M). Trolox 
was used as reference antioxidant molecule, (positive 
control); negative control was only EO vehicle (DMSO 
10%). Reactions were carried out for 30 min at 37 °C. 
After cooling, samples (0.5 mL) were centrifuged with 0.5 
mL of trichloroacetic acid (15%) at 1200 g for 10 min. 
An aliquot of 0.5 mL from supernatant was mixed with 
0.5 mL TBA (0.67%) and heated at 95 °C for 30 min. 
After cooling, samples absorbance was measured using a 
spectrophotometer at 532 nm. The results were expressed 
as percentage of TBARS formed by AAPH alone (induced 
control) (Draper & Hadley, 1990). 
Hydroxyl scavenging activity 
 The formation of •OH (hydroxyl radical) from 
Fenton reaction was quantified using 2-deoxyribose 
oxidative degradation. The principle of the assay is the 
quantification of the 2-deoxyribose degradation product, 
Malondialdehyde (MDA), by its condensation with 
2-thiobarbituric acid (TBA). Briefly, typical reactions were 
started by the addition of Fe2+ (6m M final concentration) 
to solutions containing 5 mM 2-deoxyribose, 100 mM 
H2O2 and 20 mM phosphate buffer (pH 7.2). To measure 
EO antioxidant activity against hydroxyl radical, different 
concentrations of EO were added to the system before 
Fe2+ addition. Reactions were carried out for 15 min at 
room temperature and were stopped by the addition of 
4% phosphoric acid (v/v) followed by 1% TBA (w/v, in 
50 mM NaOH). Solutions were boiled for 15 min at 95 
°C, then cooled at room temperature. The absorbance was 
measured at 532 nm and results were expressed as MDA 
equivalents formed by Fe2+ and H2O2 (Payá et al., 1994).
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Statistical analysis
 The data obtained were evaluated by one-way 
analysis of variance (ANOVA) followed by Dunnett`s or 
Fisher`s tests. Differences were considered to be statistically 
significant when p<0.05. The percent of antinociceptive 
inhibition was evaluated for each experimental group 
using the following formula (Reanmongkol et al., 1994): 
Inhibition %=100 x (control-experiment)/control.
Results
Analysis of the essential oil by GC/MS
 GC-MS analysis showed a mixture of compounds, 
with khusimol (19.57%), E-isovalencenol (13.24%), 
α-vetivone (5.25%), vetiselinenol (5.08%), α-cadinol 
(5.01%), α-vetivone (4.87%) and hydroxy-valencene 
(4.64%) as the major compounds in the EO (Table 1). 
 The analysis of the vetiver oil showed the 
presence mainly the tricyclic sesquiterpene khusimol, 
and the bicyclic sesquiterpenes (E)-isovalencenol. 
Some species showed variable oil composition, 
these differences often separate them into several 
chemotypes. The biosynthesis of secondary metabolites, 
although controlled genetically, is strongly affected 
by environmental, harvest and post-harvest factors. 
Agricultural factors have a critical effect on quantitative 
and qualitative characteristics of some Poaceae (such 
as citronella or vetiver oils), which affect plant growth 
and yield. Kim et al. (2005) and Massardo et al. (2006) 
found a large variation on volatile oil yield and content 
depending on seasonal changes and harvesting time. 
This variability of metabolism causes changes in the 
biological effect of essential oil and in concentration of 
the mainly compounds (Oliveira et al., 2009). Massardo 
reported that the major components in vetiver essential 
oil were identified as (E)-isovalencenol (19.5 to 25.0%), 
khusimol (11.1 to 12.9%) and zizanoic acid (4.4 to 
5.7%). These authors reported that vetiver essential 
oil production is closely related to the metabolism of 
plant, which is affected by changes in environmental 
temperatures.
Pharmacological assays 
 In the acetic acid-induced writhing test, the 
antinociceptive effect, represented by writhe reduction, 
elicited by 50 and 100 mg/kg of EO (6.3±1.6 and 4.6±2.0) 
in mice was similar to that of morphine 3 mg/kg (0.7±0.2), 
a standard opioid drug, when both groups were compared 
with control (13.1±2.1). EO in dose of 25 mg/kg did not 
produce any significant effect (Table 2).
 It was observed that naloxone (1.5 mg/kg, i.p.) 
antagonized the antinociceptive response of morphine 
from 0.7±0.2 (with vehicle only) to 11.8±2.4 (with vehicle 
plus naloxone) writhes in the acetic acid-induced writhing 
test. Naloxone (1.5 mg/kg, i.p.) partially reversed the 
antinociceptive effect of the EO (100 mg/kg, i.p.) (Table 
2).
Table 1. Essential oil composition of Chrysopogon zizanioides.
RT (min)a Compoundsb (%) IKc
25.017 prezizaene 0.15 1444
25.167 khusimene 0.19 1455
25.925 γ-gurjunene 0.66 1478
26.242 β-vetispirene 0.32 1488
26.350 γ-amorphene 0.11 1491
28.125 elemol 0.18 1547
28.283 β-vetivenene 0.13 1552
28.583 maaliol 1.60 1562
29.525 viridiflorol 0.34 1592
29.900 khusimone 1.09 1605
30.000 β-atlantol 0.46 1608
30.417 junenol 3.58 1622
30.708 10-epi-γ-eudesmol 0.54 1632
30.758 cubenol 0.77 1634
31.042 1,7-diepi-α-cedrenal 0.38 1643
31.375 α-cadinol 5.01 1654
31.825 mustakone 2.75 1669
32.050 2-epi-ziza-6(13)-em-3-ol 2.79 1677
32.658 junicedranol 1.90 1697
33.083 nootkatol 0.53 1712
33.383 vetiselinenol 5.08 1723
33.567 (Z)-β-curcumen-12-ol 1.50 1730
33.875 hydroxy-valencene 4.64 1740
34.058 khusimol 19.57 1747
35.150 (E)-isovalencenol 13.24 1786
35.267 spirovetiva-3,7-(11)-dien-12-ol 2.06 1790
35.608 nootkatone 1.57 1801
35.642 vetivenic acid 1.64 1803
35.858 β-vetivone 4.87 1808
36.558 α-vetivone 5.25 1825
Total identified 82.90
aRetention time; bCompounds listed in order of elution from an DB-5MS 
column; cKovats indices were calculated against n-alkanes (C9-C18) on a 
DB-5MS column; NI: Not Identified
 EO inhibited the licking response to the injected 
paw when 50 mg/kg (62.3±23.7 s) and 100 mg/kg 
(19.9±7.4 s) were administered i.p. in mice compared with 
the control group (144.0±20.2 s) in the second phase of the 
formalin test. However, EO or aspirin did not inhibit the 
licking response in first phase of the formalin test (Table 
3).
 Moreover, the hot plate test evaluated a possible 
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 Carrageenan (500 µg/cavity) induced leukocyte 
migration to the peritoneal cavity 4 h after stimulus. 
Figure 1 shows the inhibitory effect of EO on carrageenan-
induced responses in a dose-dependent manner (34.7, 35.4, 
and 62.5% at doses of 25, 50, and 100 mg/kg, respectively, 
p<0.05).
Figure 1. Effect of EO on leukocyte migration into the peritoneal 
cavity induced by carrageenan in rats. Groups of rats were 
pre-treated with vehicle (C, control group, 10 mL/kg, i.p.), 
dexamethasone (Dexa, 2 mg/kg, s.c.), or EO in concentrations 
of 25, 50, and 100 mg/kg (i.p.) 30 min before carrageenan (500 
µg/cavity, 500 µL, i.p.)-induced peritonitis. Cell counts were 
performed at the time 4 h after the injection of carrageenan. Each 
value represents the mean±S.E.M. Asterisks denote statistical 
significance, *p<0.01 related to control group. ANOVA followed 
by Dunnett`s test (n=6, per group).
 The ability of EO to prevent lipid peroxidation 
was analyzed (omitting Figure). We observed that all 
concentrations of EO were not able to prevent AAPH-
induced lipoperoxidation as assessed by the in vitro 
TBARS assay. Besides, we observed that EO was did 
central antinociceptive effect of the EO since this is 
considered a specific test for central pain analysis. EO 
did not interfere with nociception in this test (data not 
shown).
 In the rota-rod test, EO-treated mice did not show 
any significant motor performance alterations with the 
doses of 50, 100, or 200 mg/kg (data no shown). As might 
be expected, the CNS depressant diazepam (1.5 mg/kg) 
reduced the time of treated animals on the Rota-rod after 
30 min (54.8±19.0) of treatment with this standard drug.
 Table 4 shows that EO, in higher dose, inhibited 
all three phases (52.8, 39.1, and 39.7% at dose 100 mg/kg) 
of the carrageenan-induced rat paw edema equally well, 
suggesting that the EO has a non-selective inhibitory effect 
on the release or actions of these mediators.
Table 2. Effect of EO or morphine on writhing induced by acetic 
acid.
Treatment Dose (mg/kg) Number of writhingsa Inhibition (%)
Vehicle - 13.1±2.1 -
EO 25 11.3±1.9 13.7
EO 50 6.3±1.6b 51.9e
EO 100 4.6±2.0c 64.9e
EO+NAL 100+1.5 10.7±2.8 18.3
MOR 3 0.7±0.2d 94.7f
MOR+NAL 3+1.5 11.8±2.4 9.9
NAL: naloxone; MOR: morphine; n=10; a Values represent mean±SEM. 
bp<0.05, cp<0.01 and dp<0.001 (ANOVA and Dunnett`s test), significantly 
different from control; ep<0.01 and fp<0.001 (Fisher`s test), significantly 
different from control.
Table 4. Inhibitory effect of EO or aspirin on carrageenan-induced paw edema in rats. 
Table 3. Effect of EO or aspirin on formalin-induced pain.
Treatment Dose (mg/kg)
Number of licks (s)
0-5 min 15-30 min
Score of paina Inhibition (%) Score of paina Inhibition (%)
Vehicle - 48.4±4.3 - 144.0±20.2 -
EO 25 40.9±3.9 15.5 98.6±25.6b 31.5d
EO 50 37.1±4.6 23.3 62.3±23.7b 56.7e
EO 100 38.9±6.7 19.6 19.9±7.4c 86.2f
Aspirin 200 41.4±9.7 14.5 45.9±29.6b 68.1e
n=10; aValues represent mean±SEM; bp<0.05 and cp<0.001 (one-way ANOVA and Dunnett`s test), significantly different from control; dp<0.05, 

























Paw volume increase (mL)a Inhibition (%)
1 h 2 h 3 h 1 h 2 h 3 h
Vehicle - 0.36±0.07 0.69±0.11 0.73±0.10 - - -
EO 25 0.29±0.10 0.71±0.07 0.65±0.09 14.4 - 2.9 11.0
EO 50 0.31±0.08 0.59±0,15 0.58±0.09 13.9 14.5 20.6
EO 100 0.17±0.03b 0.42±0.04b 0.44±0.02c 52.8e 39.1d 39.7d
Aspirin 300 0.09±0.03c 0.28±0.02c 0.39±0.03c 75.0e 59.4e 46.6d
n=6, per group; aValues represent mean±SEM; bp<0.01 and cp<0.001 (one-way ANOVA and Dunnett`s test), significantly different from control; 
dp<0.05 and ep<0.01 (Fisher`s test), significantly different from control.
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not prevent 2-deoxyribose degradation by a hydroxyl-
generating system at any tested doses. However, at the 
concentration of 1 mg/mL, EO enhanced hydroxyl-
mediated 2-deoxyribose degradation.
Discussion
 Chrysopogon zizanioides (L.) Roberty, Poaceae, 
is one of the most important raw materials in perfumery 
and has been used in folk medicine for the treatment 
of inflammatory pain in Brazilian Northeast (oral 
communication) (Lima, 2010). The main goal of this 
study was to evaluate the phythochemical screening, 
antinociceptive and anti-inflammatory activities of C. 
zizanioides essential oil (EO) in rodents.
 GC-MS analysis of C. zizanioides EO exhibited 
a mixture of compounds similarly to a previous study of 
Weyerstahl et al. (2000a,b), Kim et al. (2005) and Adams 
et al. (2008). Among the odorous components in vetiver 
oils from different sources, khusimol, E-isovalencenol, 
α-vetivone, vetiselinenol, α-cadinol and are the major 
constituents, and their presence is often considered as the 
fingerprint of the oil.
 The first test used for pharmacological evaluation 
was the writhing test. Past studies have postulated that 
the acetic acid acts indirectly by inducing the release of 
endogenous mediators which stimulate the nociceptive 
neurons sensitive to nonsteroidal anti-inflammatory drugs 
(NSAIDs) and opioids (Fischer et al., 2008). Although 
abdominal writhing induced by acetic acid represents 
a peripheral nociception model (Wei et al., 1986) and 
is normally used for screening synthetic and natural 
compounds, this is not a specific model, since several 
compounds, including opioid analgesics (Gomes et al., 
2005) tricyclic antidepressants (Carter & Sullivan, 2002) 
and antihistaminic compounds (Koster et al., 1959) inhibit 
acetic acid induced writhing. Based in our result, it can 
be assumed that the mode of action of this activity might 
involve a peripheral mechanism. 
 The formalin test has an advantage over other 
frequently used tests as it involves a biphasic response 
with an early and a late phase representing neurogenic 
and inflammatory pain and agents can be screened for 
activity in these two models of pain (Hunskaar and Hole, 
1987). Neither EO or aspirin (200 mg/kg) decreased the 
paw licking time during the neurogenic (0-5 min) phase 
1. However, the inflammatory phase (late phase) was 
significantly inhibited by aspirin and by EO. Moreover, the 
hot plate test checked a possible central antinociceptive 
effect of the EO since this is considered a specific test for 
central pain analysis. EO did not interfere with nociception 
in this test (data not shown).
 Previous studies suggested that the CNS 
depression and the nonspecific muscle relaxation effect 
can reduce the response of motor coordination and 
consequently might invalidate the nociceptive behavioral 
tests results (Gonçalves et al., 2008). We did not see any 
interference with the motor coordination of the animals in 
the rota-rod test, therefore eliminating a nonspecific muscle 
relaxation effect of EO at the doses used. Various mediators 
are released by carrageenan in the rat paw. Thus, while 
the initial phase may be due to the release of histamine 
and serotonin, kinins may play a role in the middle phase 
(Di Rosa and Sorrentino, 1968) and prostaglandins could 
be the most important mediators in the final 3-5 h post-
carrageenan response (Vinegar et al. 1969).
 Corroborating the relevant anti-inflammatory 
activity of EO, we observed that the leukocyte migration to 
peritoneal cavity was strongly reduced by the all doses of 
EO. According to Bradley et al. (1982) the cell migration 
inhibition in models of inflammation has been considerated 
a convincing indicator of anti-inflammatory activity. The 
ability of the EO, in this study, to suppress abdominal 
writhes, inhibit the second phase of formalin induced pain 
as well as suppress the carrageenan- induced inflammation 
confirms the analgesic and anti-inflammatory activities of 
the EO.
 The lipoperoxidation and hydroxyl-scavenging 
activity assays showed that EO does not act as an 
antioxidant, since EO was not able to prevent the 
lipoperoxidation damage to an lipid enriched system 
where a free radical source (AAPH) is added; besides, 
EO was also ineffective in prevent the degradation of 
2-deoxyribose by hydroxyl radicals generated in vitro 
through Fenton reaction. As a matter of fact, the highest 
concentration of EO tested further enhanced the damage 
caused by hydroxyl. Altogether these results indicate that 
the effects of EO observed in this and other studies are 
nor mediated by free radicals or by a possible antioxidant 
activity.
 Based on our results it is possible to conclude that 
EO has potential antinociceptive and anti-inflammatory 
activities, which might involve a peripheral mechanism, 
such as, inhibiting the synthesis or action of prostaglandins. 
However, further studies will enable as to understand the 
precise action mechanisms and toxicity of this plant. 
 Furthermore, some studies attribute the anti-
inflammatory activity of vetiver oil to its secondary 
metabolites, such as khusimol, E-isovalencenol, 
α-vetivone, vetiselinenol, α-cadinol and β-vetivone 
(Hammer et al., 1999; Güllüce et al., 2003). 
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